Your browser doesn't support javascript.
loading
Scoring system for optimal cord blood unit selection for single cord blood transplantation.
Watanabe, Mizuki; Konuma, Takaaki; Imahashi, Nobuhiko; Terakura, Seitaro; Seo, Sachiko; Morishima, Satoko; Uchida, Naoyuki; Doki, Noriko; Tanaka, Masatsugu; Nishida, Tetsuya; Kawakita, Toshiro; Eto, Tetsuya; Takahashi, Satoshi; Sawa, Masashi; Uehara, Yasufumi; Kim, Sung-Won; Ishimaru, Fumihiko; Ichinohe, Tatsuo; Fukuda, Takahiro; Atsuta, Yoshiko; Kanda, Junya.
Afiliação
  • Watanabe M; Department of Hematology, Kyoto University Hospital, Kyoto, Japan; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Konuma T; Department of Hematology and Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Imahashi N; Department of Hematology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Terakura S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Morishima S; Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
  • Uchida N; Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
  • Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan.
  • Nishida T; Department of Hematology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Aichi, Japan.
  • Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Takahashi S; Division of Clinical Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Sawa M; Department of Hematology and Oncology, Anjo Kosei Hospital, Aichi, Japan.
  • Uehara Y; Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Fukuoka, Japan.
  • Kim SW; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ishimaru F; Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Fukuda T; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Aichi, Japan; Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Aichi, Japan.
  • Kanda J; Department of Hematology, Kyoto University Hospital, Kyoto, Japan. Electronic address: jkanda16@kuhp.kyoto-u.ac.jp.
Cytotherapy ; 26(3): 286-298, 2024 03.
Article em En | MEDLINE | ID: mdl-38149949
ABSTRACT

BACKGROUND:

We conducted a retrospective study to categorize the cord blood unit (CBU)s to identify the optimal units.

METHODS:

A total of 8503 adults (female, n = 3592; male, n = 4911) receiving their first single cord blood transplantation (CBT) in 2000-2019 were analyzed. Factors associated with CBUs affecting overall survival (OS) and neutrophil engraftment were selected to create ranked categorization for each outcome, followed by comparison with transplantation using HLA-matched bone marrow (BMT)/peripheral blood stem cell (PBSCT) from unrelated (n = 6052) and related donors (n = 4546).

RESULTS:

Sex-mismatch, CD34+ cell and CFU-GM counts were selected in the OS analysis. Considering the strong interaction between sex mismatch and CD34+ cell counts, we analyzed females and males separately. For females, female CBU with CD34+ cell counts {greater than or equal to} 0.5 × 10e5/kg and CFU-GM counts {greater than or equal to} 15 × 10e3/kg offered the best OS (Group I), followed by other groups with any (Groups II-IV) or all (Group V) of the risk factors. Group I consistently showed favorable OS (Group IV HR1.22, P = 0.027; Group V HR1.31, P = 0.047), comparable to those of rBMT/PBSCT (OS HR1.02, P = 0.654) and uBM/PBSCT in patients with higher rDRI (HR1.07, P = 0.353). Male patients lacked significant factors affecting OS. Categorization for neutrophil engraftment consisting of CD34+ cell and CFU-GM counts, sex-mismatch, presence of donor-specific antibodies, and the number of HLA-mismatches was effective but not predicted OS.

CONCLUSION:

Our ranked categorizations sufficiently predicted female OS and engraftment. The best-ranked CBUs offered preferable outcomes comparable to conventional BM/PB donors in female but not in male patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Doença Enxerto-Hospedeiro Limite: Adult / Female / Humans / Male Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Doença Enxerto-Hospedeiro Limite: Adult / Female / Humans / Male Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão